期刊文献+

Toll样受体3抑制胰岛β细胞生长的分子机制研究 被引量:1

Effect of Toll-like receptor 3 on the proliferation of pancreatic β-cell
下载PDF
导出
摘要 目的:探索Toll样受体3(Toll-like receptor 3,TLR3)在调节大鼠胰岛β细胞株INS-1细胞生长中的作用及其相关机制。方法:采用1%牛血清白蛋白(BSA)代替血清培养12 h使INS-1细胞同步化处于G0期。TLR3的特异性激动剂聚肌胞(polyinosinic-polycytidylic acid,PIC)激活TLR3,26S蛋白酶体抑制剂MG132抑制蛋白酶体活性。MTT法检测细胞活力,流式细胞术测定细胞周期,实时定量RT-PCR、免疫印迹(Western blot)法检测细胞周期相关蛋白Cyclin D1的表达。结果:和对照组相比,PIC呈剂量依赖性抑制INS-1细胞生长活力(P<0.05);PIC能显著阻滞INS-1细胞周期于G1期(P<0.05);PIC处理组Cy-clin D1的mRNA水平无明显变化(P>0.05),但其蛋白水平显著下调(P<0.05);给予蛋白酶体抑制剂MG132预处理能缓解此下调作用。结论:激活的TLR3可能通过蛋白酶体介导的Cyclin D1降解,导致胰岛β细胞G1期阻滞,从而抑制其增殖,参与机体胰岛β细胞整体功能障碍的调节。 Objective:To investigate the effect of elevated Toll-like receptor 3(TLR3) On the growth of INS-1 pancreatic β-cell and possible cell cycle changes during this process. Methods:INS-1 cells were synchronized at the GO phase by serum deprivation for 12 h. Polyinosinie-polycytidylie acid (PIC) was used to activate TLR3, and the proteasome was inhibited with MG132. Cell viability was assessed by MTT colorimetric assay. Cell cycle distribution was measured by FACS analysis,and cell cycle protein Cyclin D1 was further detected using real-time RT-PCR and Western blot analysis. Results:PIC significantly inhibited the viability of INS-1 cells in a,dose-dependent manner (P 〈 0.05). Furthermore,PIC induced an increase in the proportion of cells at the G1 phase and a corresponding decrease in the number of cells at the S phase (P 〈 0.05). Additionally,PIC treatment caused a significant reduction in Cyclin D1 levels (P 〈 0.05),but without a parallel decrease in Cyclin D1 mRNA levels(P 〉 0.05). Inhibition of the proteasome with MG132 rescued Cyclin D 1 protein from degradation. Conclusion:The results suggest that TLR3 activation with PIC directly inhibits pancreat- ic β-cell proliferation through cell cycle arrest at the G1 phase,possibly by downregulation of Cyclin D1 in a proteasome-dependent manner,which ultimately results in an overall β-cell mass deficiency.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第5期621-625,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(81170714)
关键词 胰岛Β细胞 TOLL样受体3 聚肌胞 CYCLIN D1 细胞周期 pancreatic β-cell TLR3 polyinosinic-polycytidylic acid Cyclin D 1 cell cycle
  • 相关文献

参考文献16

  • 1Bruno ME, Frantz AL, Rogier EW, et al. Regulation of the polymeric immunoglobalin receptor by the classical and alternative NF-KB pathways in intestinal epithelial cells [J]. Mucosal Immunol, 2011,4(4) :468-478.
  • 2Ehses JA, Meier DT, Wueest S, et al. Toll-like receptor 2- deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet[J]. Dia- betologia, 2010,53 (8) : 1795-1806.
  • 3Zimmer S,Steinmetz M,Asdonk T,et al. Activation of en- dothelial Toll-like receptor 3 impairs endothelial function [J]. Circ Res, 2011,108(11) : 1358-1366.
  • 4Dogusan Z,Garcia M,Flamez D,et al. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the Toll-like receptor 3 and interferon regulatory factor 3 pathways [ J ]. Diabetes, 2008,57 ( 5 ) : 1236-1245.
  • 5朱大龙.对代谢性疾病病因学研究的思考[J].中国糖尿病杂志,2007,15(10):581-582. 被引量:1
  • 6陈海冰,贾伟平.糖尿病与免疫[J].临床内科杂志,2007,24(3):159-161. 被引量:14
  • 7Dasu MR, Devaraj S, Park S, et al. Increased Toll-like receptor(TLR) activation and TLR ligands in recently diag- nosed type 2 diabetic subjects [J]. Diabetes Care, 2010,33(4) :861-868.
  • 8Wang YZ,Liang QH,Ramkalawan H,et al. Expression of Toll-like receptors 2,4 and 9 in patients with gaillain- barre syndrome [J]. Neuroimmunomodulation,2012,19 (1):60-68.
  • 9Reyna SM, Ghosh S,Tantiwong P, et al. Elevated Toll-like receptor 4 expression and signaling in muscle from in- sulin-resistant subjects [J]. Diabetes,2008,57 (10): 2595"2602.
  • 10Lath!a JD,Okun E,Tang SC,et al. Toil-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation [J]. J Neurosci, 2008,28 (51 ) : 13978-13984.

二级参考文献24

  • 1Hammond KJ,Kronenberg M.Natural killer T cells:natural or unnatural regulators of autoimmunity? Curr.Opin.Immunol.2003,15:683-689.
  • 2Camara NO,Ng WF,Hernandes-Fuentes M,et al.Human CD+4CD+25T cells regulate CD+8 T-cell activation.Transplant Proc,2002,34:2858-2860.
  • 3Feili-Hariri M,Falkner DH,Morel PA.Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.Eur J Immunol,2002,32:2021-2030.
  • 4Alard P,Manirarora JN,Parnell SA,et al.Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD+4CD+25 T-cell-mediated regulation and type 1 diabetes development in NOD mice.Diabetes,2006,55:2098-2105.
  • 5Bouwman LH,Eerligh P,Terpstra OT,et al.Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles.Diabetes,2005,54:3002-3006.
  • 6Medzhitov R,Janeway C.Innate immunity.N Engl J Med,2000,343:338-344.
  • 7Huth C,Heid IM,Vollmert C,et al.IL6 gene promoter polymorphisms and type 2 diabetes:joint analysis of individual participants'data from 21 studies.Diabetes,2006,55:2915-2921.
  • 8Gupta D,Varma S,Khandelwal RL.Long-term effects of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt/PKB.J Cell Biochem,2007,100:593-607.
  • 9Natali A,Toschi E,Baldeweg S,et al.Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.Diabetes,2006,55:1133-1140.
  • 10Petrovsky N,Silva D,Socha L,et al.The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice.Ann N Y Acad Sci,2002,958:204-208.

共引文献13

同被引文献16

  • 1Cao L,Ge X,Gao Y,et al. Porcine epidemic diarrhea virus inhibits dsRNA-induced interferon-beta production in porcine intestinal epithelial cells by blockade of the RIG-I-mediated pathway[ J ]. ~irol J, 2015,12:127.
  • 2Xu J,Mercado-Lopez X,Grier J T,et al. Identification of a natural viral RNA motif that optimizes sensing of viral RNA by RIG-I[J]. MBio,2015,6(5):e1215-e1265.
  • 3Aida K,Nishida Y,Tanaka S,et al. RIG-I- and MDA5- initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes [J]. Diabetes, 2011,60(3) : 884-889.
  • 4Shoemaker R,Yiannikouris F,Thatcher S,et al. ACE2 de- ficiency reduces beta-cell mass and impairs beta-cell proliferation in obese C57BL/6 mice [J]. Am J Physiol Endocrinol Metab, 2015,309 (7) : E621-E631.
  • 5Alonso-Magdalena P, Garcia-Arevalo M, Quesada I,et al. Bisphenol-A treatment during pregnancy in mice:a new window of susceptibility for the development of diabetes in mothers later in life~J]. Endocrinology,2015,156(5): 1659-1670.
  • 6Yaghootkar H, Stancakova A, Freathy RM, et al. Associa- tion analysis of 29,956 individuals confirms that a low- frequency variant at CCND2 halves the risk of type 2 di- abetes by enhancing insulin secretion~J]. Diabetes, 2015,64(6) : 2279-2285.
  • 7Wang Y, Wu H, Gao L, et al. Elevated toll-like receptor 3 inhibits pancreatic beta-cell proliferation through G1 phase cell cycle arrest[J]. Mol Cell Endocrinol,2013,377 (1-2) : 112-122.
  • 8Chen SS,Jiang T,Wang Y,et M. Activation of double- stranded RNA-dependent protein kinase inhibits prolifer- ation of pancreatic beta-cells [J]. Biochem Biophys Res Commun, 2014,443 (3) : 814-820.
  • 9Song Y,Wan X,Gao L,et al. Activated PKR inhibits pancreatic beta-cell proliferation through sumoylation-de- pendent stabilization of P53 [J]. Mol Immunol,2015,68 (2 Pt A) :341-349.
  • 10Gao L,Tang W,Ding Z,et al. Protein-binding function of RNA-dependent protein kinase promotes proliferation through TRAF2/RIP1/NF-kappaB/c-Myc pathway in pancreatic beta cells[J]. Mol Med,2015,21:154-166.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部